The role of methadone in opioid rotation-a Polish experience

Supportive Care in Cancer

Volumn 17, Issue 5, 2009, Pages 607-612

  Leppert, Wojciech ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Cancer pain; Methadone; Opioid analgesics; Opioid rotation; Opioid switch

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BUPIVACAINE; FENTANYL; KETAMINE; KETOPROFEN; METHADONE; MORPHINE; NALOXONE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PAMIDRONIC ACID; PETHIDINE; THIAMAZOLE; TRAMADOL;

ADJUVANT THERAPY; ADULT; AGED; ANALGESIA; ARTICLE; BREAKTHROUGH PAIN; CANCER PAIN; CANCER PATIENT; CLINICAL ARTICLE; CONFUSION; CONSTIPATION; DOSE CALCULATION; DROWSINESS; DRUG DOSE INCREASE; DRUG FATALITY; DRUG SUBSTITUTION; DRUG TOLERANCE; DRUG WITHDRAWAL; DYSPHAGIA; FEMALE; HUMAN; MALE; NAUSEA; NAUSEA AND VOMITING; PRIORITY JOURNAL; RESPIRATION DEPRESSION; SIDE EFFECT; SWEATING; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; ANALGESICS, OPIOID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; FEMALE; HUMANS; MALE; METHADONE; MIDDLE AGED; MORPHINE; NEOPLASMS; PAIN; POLAND; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 64449086195     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-008-0537-7     Document Type: Article

References (45)

1. OT Ayonrinde DT Bridge 2000 The rediscovery of methadone for cancer pain management Med J Aust 173 536 540
2. EA Bolan RJ Tallarida GW Pasternak 2002 Synergy between μ opioid ligands: evidence for functional interactions among μ opioid receptor subtypes J Pharmacol Exp Ther 303 557 562
3. E Bruera JN Palmer S Bosnjak MA Rico J Moyano 2004 Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study J Clin Oncol 22 1 185 192
4. E Bruera J Pereira S Watanabe M Belzile N Kuehn J Hanson 1996 Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine Cancer 78 852 857
5. N Cherny C Ripamonti J Pereira C Davis M Fallon H McQuay S Mercadante G Pasternak V Ventafridda Expert Working Group of the European Association of Palliative Care Network 2001 Strategies to manage the adverse effects of oral morphine: an evidence-based report J Clin Oncol 19 9 2542 2554
6. EE Codd RP Schank JJ Schupsky RB Raffa 1995 Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception J Pharmacol Exp Ther 274 1263 1270
7. PJ Daeninck E Bruera 1999 Reduction in constipation and laxative requirements following opioid rotation to methadone: a report of four cases J Pain Symptom Manage 18 4 303 309
8. MP Davies 2005 Look before leaping: combined opioids may not be the rave Support Care Cancer 13 10 769 774
9. MP Davis D Walsh 2001 Methadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration Support Care Cancer 9 73 83
10. F De Conno L Groff C Brunelli E Zecca V Ventafridda C Ripamonti 1996 Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients J Clin Oncol 14 10 2836 2842
11. ND De Stoutz E Bruera M Suazer-Almazor 1995 Opioid rotation for toxicity reduction in terminal cancer patients J Pain Symptom Manage 10 5 378 384
12. B Ebert S Andersen P Krogsgaard-Larsen 1995 Ketobemidone, methadone and pethidine are non-competitive N-methyl-d-aspartate (NMDA) antagonists in the rat cortex and spinal cord Neurosci Lett 187 165 168
13. RH Enting WH Oldenmenger CCD van der Rijt EB Wilms EJ Elfrink I Elswijk PAE Sillevis Smitt 2002 A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids Cancer 94 3049 3056
14. SM Fishman B Wilsey G Mahajan P Molina 2002 Methadone reincarnated: novel clinical applications with related concerns Pain Med 3 4 339 348
15. G Gannon 1997 The use of methadone in the care of dying Eur J Palliat Care 4 5 152 158
16. G Gazelle PG Fine 2004 Methadone for pain J Palliat Med 7 2 303 304
17. NA Hagen E Wasylenko 1999 Methadone: outpatient titration and monitoring strategies in cancer patients J Pain Symptom Manage 18 5 369 375
18. GW Hanks F de Conno N Cherny M Hanna E Kalso HJ McQuay S Mercadante J Meynadier P Poulain C Ripamonti L Radbruch J Roca i Casas J Säwe RG Twycross V Ventafridda Expert Working Group of the Research Network of the European Association for Palliative Care 2001 Morphine and alternative opioids in cancer pain: the EAPC recommendations Br J Cancer 84 5 587 593
19. A Kotlińska-Lemieszek J Łuczak 2004 Subanesthetic ketamine: an essential adjuvant for intractable cancer pain J Pain Symptom Manage 28 2 100 102
20. PG Lawlor KS Turner J Hanson ED Bruera 1998 Dose ratio between morphine and methadone in patients with cancer pain. A retrospective study Cancer 82 6 1167 1183
21. W Leppert J Luczak 2005 The role of methadone in cancer pain treatment-Polish experience Prog Palliat Care 13 5 269 276
22. D Lussier AG Huskey RK Portenoy 2004 Adjuvant analgesics in cancer pain management Oncologist 9 571 591
23. IL Mancini J Hanson CM Neumann E Bruera 2000 Opioid type and other clinical predictors of laxative dose in advanced cancer patients: a retrospective study J Palliat Med 3 1 49 56
24. PL Manfredi KM Foley R Payne R Houde CE Inturissi 2003 Parenteral methadone: an essential medication for the treatment of pain J Pain Symptom Manage 26 2 687 688
25. S Mercadante 1999 Opioid rotation for cancer pain. Rationale and clinical aspects Cancer 86 1856 1866
26. S Mercadante 1998 Predictive factors and opioid responsiveness in cancer pain Eur J Cancer 34 5 627 631
27. S Mercadante 2004 Switching to methadone: "ad libitum" or fixed dose ratio? Palliat Med 18 71
28. S Mercadante M Bianchi P Villari P Ferrera A Casuccio F Fulfaro V Gebbia 2003 Opioid plasma concentration during switching from morphine to methadone: preliminary data Support Care Cancer 11 5 326 331
29. S Mercadante A Casuccio A Agnello L Barresi 1999 Methadone response in advanced cancer patients with pain followed at home J Pain Symptom Manage 18 3 188 192
30. S Mercadante A Casuccio L Calderone 1999 Rapid switching from morphine to methadone in cancer patients with poor response to morphine J Clin Oncol 17 10 3307 3312
31. S Mercadante A Casuccio F Fulfaro L Groff R Boffi P Villari V Gebbia C Ripamonti 2001 Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study J Clin Oncol 19 11 2898 2904
32. S Mercadante P Ferrera P Villari E Arcuri 2003 Hyperalgesia: an emerging iatrogenic syndrome J Pain Symptom Manage 26 2 769 775
33. S Mercadante P Villari P Ferrera A Casuccio 2004 Addition of a second opioid may improve opioid response in cancer pain: preliminary data Support Care Cancer 12 11 762 766
34. J Morley M Mankin 1998 The use of methadone in cancer pain poorly responsive to other opioids Pain Rev 5 51 58
35. N Moryl J Santiago-Palma C Kornick S Derby D Fischberg R Payne PL Manfredi 2002 Pitfalls of opioid rotation: substituting another opioid for methadone in patients with cancer pain Pain 96 325 328
36. C Ripamonti M Bianchi 2002 The use of methadone for cancer pain Hematol Oncol Clin North Am 16 3 543 555
37. C Ripamonti M Bianchi E Bruera 2004 Methadone: an orphan drug? J Palliat Med 7 1 73 74
38. C Ripamonti L Groff C Brunelli D Polastri A Stavrakis F De Conno 1998 Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? J Clin Oncol 16 10 3216 3221
39. C Ripamonti E Zecca C Brunelli E Rizzio L Salta F Lodi F De Conno 1995 Rectal methadone in cancer patients with pain. A preliminary clinical and pharmacokinetic study Ann Oncol 6 841 843
40. MA Simmonds R Payne J Richenbacher K Moran NA Southam MS Hershey 1989 TTS (fentanyl) in the management of pain in patients with cancer Proc Am Soc Clin Oncol 8 324
41. E Spina J de Leon 2007 Metabolic drug interactions with newer antipsychotics: a comparative review Basic Clin Pharmacol Toxicol 100 1 4 22
42. R Twycross I Back 1998 Nausea and vomiting in advanced cancer Eur J Palliat Care 5 2 39 45
43. S Watanabe M Belzile N Kuehn J Hanson E Bruera 1996 Capsules and suppositories of methadone for patients on high-dose opioids for cancer pain: clinical and economic considerations Cancer Treat Rev 22 suppl. 1 131 136
44. DJ Weschules KT Bain 2008 A systematic review of opioid conversion ratios used with methadone for the treatment of pain Pain Med 9 5 595 612
45. DJ Weschules KT Bain S Richeimer 2008 Actual and potential drug interactions associated with methadone Pain Med 9 3 315 344